Category: Syneron Medical Ltd.
Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Syneron and Unilever subsidiaries have established a joint venture for home beauty devices, causing Syneron shares to jump by around 16%, this week.
Syneron Medical Ltd. (NSDQ:ELOS) stock surged by 16% for the week after its subsidiary, Syneron Beauty, said it will partner with Unilever Ventures's Iluminage Inc., on a joint venture, to be called Iluminage Beauty.
Syneron wins 510(k) clearance from the FDA and CE Mark approval in the European Union for its VelaShape III device.
Syneron Medical Ltd. (NSDQ:ELOS) said it won a pair of regulatory nods for its VelaShape III "body shaping" device.
Syneron Medical's 2nd-quarter earnings meet Wall Street's expectations, but sales fall short, sending shares down on The Street.
Syneron Medical Ltd. (NSDQ:ELOS) stumbled during the 2nd quarter, posting earnings that were even with Wall Street's forecast but just missing sales expectations, sending share prices down this week.
Israel-based cosmetics company Syneron lands approval in Korea for its Elure melanin-reducing product, a big win in the overall Asian market, which represents 95% of skin-lightening product sales.
Israel-based aesthetic device company Syneron Medical (NSDQ:ELOS) landed Korean regulatory approval for its elure skin-lightening product, a victory the company touts as crucial in a high-demand market.
Jawbone reportedly agrees to pay more than $100 million for wearable sensor maker BodyMedia.
Jawbone agreed to acquire BodyMedia, reportedly for more than $100 million, in a bid to expand its footprint in the wearable technology market.
San Francisco-based Jawbone did not disclose the deal's value, but Reuters, citing "a person familiar with the matter," reported that it's worth "north of $100 million."
Pittsburgh-based BodyMedia's roughly 60 employees will "join Jawbone's existing team," according to a press release.
Louis Scafuri walks away from the corner office at aesthetic medical device company Syneron, making way for co-founder Shimon Eckhouse to take the reins as CEO.
After 4 years at the helm of Yokham, Israel-based Syneron Medical (NSDQ:ELOS), Louis Scafuri is walking away from the corner office of the aesthetic medical device company effective immediately.
Co-founder Shimon Eckhouse, who served as Syneron CEO from its founding in 1992 to 1999, was tapped to replace the outgoing Scafuri. Eckhouse will also serve as chairman, according to a press release.